Marco Antonio Velasco Velazquez (Marco A Velasco-Velázquez, Marco Velasco-Velázquez, Marco Antonio Velasco-Velázquez, Marco A Velasco- Velázquez, Marco A Velasco-Velásquez)

Scopus Author ID Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 28

Top Venues

Journal of chemical information and modeling

Pharmaceuticals (Basel, Switzerland)

Journal of immunology research

BioMed research international

Universidad Nacional Autónoma de México

Universidad Nacional Autónoma de México (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Nacional Autónoma de México

Mexico

Professor :: Pharmacology, School of Medicine

Education History

Universidad Nacional Autónoma de México Feb 01 1998 - Mar 30 2005

Mexico

PHD

Publications

Angel Jonathan Ruiz-Moreno, Raziel Cedillo-González, Luis Cordova-Bahena, Zhiqiang An, José L Medina-Franco, Marco Antonio Velasco Velazquez
Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 M pro Inhibitors from Large Chemical Libraries. Journal of chemical information and modeling 64 (6) (2024)
Nohemí Salinas-Jazmín, María Adriana Medina-Mondragón, Jeannie Jiménez-López, Sandra Lucia Guerrero-Rodríguez, Patricia Cuautle-Rodríguez, Marco Antonio Velasco Velazquez
Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter. Cancer chemotherapy and pharmacology (2024)
Angel Jonathan Ruiz-Moreno, Raziel Cedillo-González, Luis Cordova-Bahena, Zhiqiang An, José L Medina-Franco, Marco Antonio Velasco Velazquez
Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 M pro Inhibitors from Large Chemical Libraries. Journal of chemical information and modeling 64 (6) (2024)
Karina Eurídice Juárez-Mercado, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, Luis Córdova-Bahena, Clara Espitia, Sonia Mayra Pérez-Tapia, José Luis Medina-Franco, Marco Antonio Velasco Velazquez
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Angel Jonathan Ruiz-Moreno, Raziel Cedillo-González, Luis Cordova-Bahena, Zhiqiang An, José L Medina-Franco, Marco Antonio Velasco Velazquez
Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 M pro Inhibitors from Large Chemical Libraries. Journal of chemical information and modeling 64 (6) (2024)
Karina Eurídice Juárez-Mercado, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, Luis Córdova-Bahena, Clara Espitia, Sonia Mayra Pérez-Tapia, José Luis Medina-Franco, Marco Antonio Velasco Velazquez
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Angel Jonathan Ruiz-Moreno, Raziel Cedillo-González, Luis Cordova-Bahena, Zhiqiang An, José L Medina-Franco, Marco Antonio Velasco Velazquez
Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 M pro Inhibitors from Large Chemical Libraries. Journal of chemical information and modeling 64 (6) (2024)
Angel Jonathan Ruiz-Moreno, Raziel Cedillo-González, Luis Cordova-Bahena, Zhiqiang An, José L Medina-Franco, Marco Antonio Velasco Velazquez
Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 M pro Inhibitors from Large Chemical Libraries. Journal of chemical information and modeling (2024)
Angel Jonathan Ruiz-Moreno, Raziel Cedillo-González, Luis Cordova-Bahena, Zhiqiang An, José L Medina-Franco, Marco Antonio Velasco Velazquez
Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 M pro Inhibitors from Large Chemical Libraries. Journal of chemical information and modeling 64 (6) (2024)
César A Zaa, Clara Espitia, Karen L Reyes-Barrera, Zhiqiang An, Marco Antonio Velasco Velazquez
Neuroprotective Agents with Therapeutic Potential for COVID-19. Biomolecules 13 (11) (2023)
César A Zaa, Álvaro J Marcelo, Zhiqiang An, José Luis Medina-Franco, Marco Antonio Velasco Velazquez
Anthocyanins: Molecular Aspects on Their Neuroprotective Activity. Biomolecules 13 (11) (2023)
Afsaneh Sadremomtaz, Zayana M Al-Dahmani, Angel J Ruiz-Moreno, Alessandra Monti, Chao Wang, Taha Azad, John C Bell, Nunzianna Doti, Marco Antonio Velasco Velazquez, Debora de Jong, Jørgen de Jonge, Jolanda M Smit, Alexander S S Dömling, Harry van Goor, Matthew R Groves
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein. Journal of medicinal chemistry (2021)
Luis Córdova-Bahena, Axel A Sánchez-Álvarez, Angel Jonathan Ruiz-Moreno, Marco Antonio Velasco Velazquez
Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Angel Jonathan Ruiz-Moreno, Atilio Reyes Romero, Alexander Dömling, Marco Antonio Velasco Velazquez
In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates. Molecules (Basel, Switzerland) 26 (7) (2021)
Arely Rosas-Cruz, Nohemí Salinas-Jazmín, Marco Antonio Velasco Velazquez
Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets? Technology in cancer research & treatment 20 (2021)
Denisse Arcos-Montoya, Talia Wegman-Ostrosky, Sonia Iliana Mejía-Pérez, Marisol De la Fuente-Granada, Ignacio Camacho-Arroyo, Alejandro Manuel García Carrancá, Marco Antonio Velasco Velazquez, Joaquín Manjarrez-Marmolejo, Aliesha González-Arenas
Progesterone Receptor Together with PKCα Expression as Prognostic Factors for Astrocytomas Malignancy. OncoTargets and therapy 14 (2021)
Bárbara Lara-Chacón, Sandra L Guerrero-Rodríguez, Karla J Ramírez-Hernández, Angélica Yamilett Robledo-Rivera, Marco Antonio Velasco Velazquez, Roberto Sánchez-Olea, Mónica Raquel Calera
Gpn3 Is Essential for Cell Proliferation of Breast Cancer Cells Independent of Their Malignancy Degree. Technology in cancer research & treatment 18 (2020)
Ignacio Mejía-Calvo, Leonardo E López-Juárez, Said Vázquez-Leyva, Carlos Augusto Lopez-Morales, Daniel Montoya-Escutia, Pamela G Merlos Rivera, José Enrique Herbert-Pucheta, Luis Gerardo Zepeda-Vallejo, Marco Antonio Velasco Velazquez, Lenin Pavón, Sonia Mayra Perez-Tapia, Emilio Medina-Rivero
Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care. Journal of cosmetic dermatology 20 (1) (2020)
Inés Velázquez-Quesada, Angel Jonathan Ruiz-Moreno, Diana Casique-Aguirre, Charmina Aguirre-Alvarado, Fabiola Cortés-Mendoza, Marisol de la Fuente-Granada, Carlos García-Pérez, Sonia Mayra Perez-Tapia, Aliesha González-Arenas, Aldo Segura-Cabrera, Marco Antonio Velasco Velazquez
Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells. Drug design, development and therapy 14 (2020)
Said Vázquez-Leyva, Luis Vallejo-Castillo, Carlos Augusto Lopez-Morales, José Enrique Herbert-Pucheta, Luis Gerardo Zepeda-Vallejo, Marco Antonio Velasco Velazquez, Lenin Pavón, Sonia Mayra Perez-Tapia, Emilio Medina-Rivero
Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. Analytical chemistry 91 (22) (2019)
Gabriela Mellado-Sanchez, Juan José Lázaro-Rodríguez, Sandra Avila, Luis Vallejo-Castillo, Said Vázquez-Leyva, Gregorio Carballo-Uicab, Marco Antonio Velasco Velazquez, Emilio Medina-Rivero, Lenin Pavón, Rommel Chacón-Salinas, Sonia Mayra Perez-Tapia
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). Journal of immunology research 2019 (2019)
Alexis P Jiménez-Uribe, Hugo Valencia-Martínez, Gregorio Carballo-Uicab, Luis Vallejo-Castillo, Emilio Medina-Rivero, Rommel Chacón-Salinas, Lenin Pavón, Marco Antonio Velasco Velazquez, Gabriela Mellado-Sanchez, Sergio Estrada-Parra, Sonia Mayra Perez-Tapia
CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®). Journal of immunology research 2019 (2019)
Carlos Augusto Lopez-Morales, Said Vázquez-Leyva, Luis Vallejo-Castillo, Gregorio Carballo-Uicab, Leslie Muñoz-García, José Enrique Herbert-Pucheta, Luis Gerardo Zepeda-Vallejo, Marco Antonio Velasco Velazquez, Lenin Pavón, Sonia Mayra Perez-Tapia, Emilio Medina-Rivero
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. Journal of food science 84 (3) (2019)
Gilberto Pérez-Sánchez, Enrique Becerril-Villanueva, Rodrigo Arreola, Gabriela Martínez-Levy, María Eugenia Hernández-Gutiérrez, Marco Antonio Velasco Velazquez, Samantha Alvarez-Herrera, Carlos Cruz-Fuentes, Lino Palacios, Francisco de la Peña, Lenin Pavón
Inflammatory Profiles in Depressed Adolescents Treated with Fluoxetine: An 8-Week Follow-up Open Study. Mediators of inflammation 2018 (2018)
Silvia Anahi Valdés-Rives, Diana Casique-Aguirre, Liliana Germán-Castelán, Marco Antonio Velasco Velazquez, Aliesha González-Arenas
Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications. BioMed research international 2017 (2017)
Iván Velasco, Tilo Kunath, Verónica Ramos-Mejía, Marco Antonio Velasco Velazquez
Producing Stem Cell-Based Transplants for Future Therapeutic Purposes. Stem cells international 2017 (2017)
Dalia Ramírez-Ramírez, Eduardo Vadillo, Lourdes Andrea Arriaga-Pizano, Héctor Mayani, Sergio Estrada-Parra, Marco Antonio Velasco Velazquez, Sonia Mayra Perez-Tapia, Rosana Pelayo
Early Differentiation of Human CD11c+NK Cells with γδ T Cell Activation Properties Is Promoted by Dialyzable Leukocyte Extracts. Journal of immunology research 2016 (2016)
Emilio Medina-Rivero, Luis Vallejo-Castillo, Said Vázquez-Leyva, Gilberto Pérez-Sánchez, Liliana Favari, Marco Antonio Velasco Velazquez, Sergio Estrada-Parra, Lenin Pavón, Sonia Mayra Perez-Tapia
Physicochemical Characteristics of Transferon™ Batches. BioMed research international 2016 (2016)

Marco Antonio Velasco Velazquez.css-eqlu8i{font-size:small;padding-left:4px;} (Marco A Velasco-Velázquez, Marco Velasco-Velázquez, Marco Antonio Velasco-Velázquez, Marco A Velasco- Velázquez, Marco A Velasco-Velásquez)

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Antonio Velasco Velazquez (Marco A Velasco-Velázquez, Marco Velasco-Velázquez, Marco Antonio Velasco-Velázquez, Marco A Velasco- Velázquez, Marco A Velasco-Velásquez)